Loading…
Henan-based holding company with pharmaceutical/medical-material interests; specific products not confirmed.
Henan-based holding company with pharmaceutical/medical-material interests; specific products not confirmed.
Moat: none
Headquarters: Boai County, Henan, China · Employees: 1,186
Size Boai NKY Medical (300109.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $896M, the 2527th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥10.74 on 6 Nov 2026.
Performance Over six months the shares fell 31.9%, against -25.2% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue fell 16.6% over the last twelve months (peer median +6.3%); the operating margin is 14.8% (peer median 5.5%).
Valuation It trades at 32.5× forward earnings against a peer median of 26.1× (4th most expensive of 10).
Price implies For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +16 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.3 points below its cost of capital (9.9% WACC).
Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.21B | CN¥1.17B | CN¥1.60B | CN¥1.58B | CN¥1.48B |
| Revenue growth | — | -26% | +1% | +6% | — |
| Gross profit | CN¥577M | CN¥518M | CN¥726M | CN¥867M | CN¥674M |
| EBITDA | n/a | CN¥379M | CN¥532M | CN¥647M | CN¥444M |
| Net income | CN¥124M | CN¥190M | CN¥350M | CN¥493M | CN¥291M |
| Free cash flow | CN¥149M | CN¥118M | -CN¥18.7M | CN¥110M | -CN¥11.3M |
| Capital expenditure | CN¥174M | CN¥220M | CN¥275M | CN¥378M | CN¥266M |
| Total debt | CN¥655M | CN¥353M | CN¥501M | CN¥185M | CN¥188M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300109.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -15.8% | -12.6% | 7th lowest of 21 |
| 6-month return | -31.9% | -25.2% | 7th lowest of 21 |
| Distance from 52-week high | -39.0% | -41.1% | 11th highest of 21 |
| Revenue growth (TTM) | -16.6% | +6.3% | 6th lowest of 21 |
| Operating margin | 14.8% | 5.5% | 5th highest of 21 |
| Forward P/E | 32.5× | 26.1× | 4th most expensive of 10 |
| Growth the price implies (Req g, 7 yrs) | 19.9% | 27.0% | 7th least demanding of 14 |
| Growth delivered (Del g) | +3.9% | +4.7% | 6th lowest of 13 |
| Hurdle (Req g minus delivered) | +15.9 pp | +17.1 pp | 7th least demanding of 13 |
| ROIC minus cost of capital | -4.3 pp | -2.2 pp | 10th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Boai NKY Medical 300109.SZ | China | $896M | -32% | -17% | 15% | 32.5× | 19.9% | +3.9% |
| Sudarshan Chemical Industries SUDARSCHEM.NS | India | $893M | +10% | +90% | 4% | 28.9× | 27.0% | +39.5% |
| Henan Jindan Lactic Acid Technology 300829.SZ | China | $900M | +52% | +5% | 3% | 26.1× | n/a | n/a |
| TETRA Technologies TTI | United States | $891M | -39% | +6% | 7% | 19.9× | n/a | n/a |
| Longkou Union Chemical 301209.SZ | China | $904M | -39% | -3% | 9% | 336.5× | 36.9% | +1.6% |
| Sichuan Xinjinlu 000510.SZ | China | $906M | -32% | -4% | -15% | n/a | n/a | n/a |
| Shenzhen Wote Advanced Materials 002886.SZ | China | $906M | -15% | +10% | 4% | 68.2× | 31.3% | +12.2% |
| Guangzhou Human New Material Science & Technology 301683.SZ | China | $918M | -25% | +20% | 38% | n/a | 11.3% | n/a |
| Zhejiang Wansheng 603010.SS | China | $872M | -25% | +19% | -26% | n/a | n/a | n/a |
| Changzhou Tronly New Electronic Materials 300429.SZ | China | $923M | -37% | +14% | -14% | n/a | 56.6% | +5.0% |
| Quechen Silicon Chemical 605183.SS | China | $926M | -12% | +7% | 19% | n/a | 2.0% | +16.1% |
| Green Plains GPRE | United States | $927M | -27% | -22% | 7% | 7.4× | -1.0% | +1.8% |
| Jiangsu Chengxing Phosph-Chemicals 600078.SS | China | $928M | -29% | +27% | 13% | n/a | 2.6% | +2.9% |
| Hanking Gold International 3788.HK | Hong Kong | $862M | -26% | -19% | 8% | n/a | n/a | n/a |
| Rastar Environmental Protection Materials 300834.SZ | China | $933M | -9% | -23% | 1% | n/a | 43.9% | 0.0% |
| Kronos Worldwide KRO | United States | $859M | +46% | +3% | -1% | 11.9× | 17.6% | +2.6% |
| Zhejiang Oceanking Development 603213.SS | China | $938M | +1% | -17% | 0% | n/a | 38.3% | +17.9% |
| Daqo New Energy Corp Sponsored ADR DQ | United States | $856M | -32% | -21% | -70% | n/a | n/a | n/a |
| Shandong Head 002810.SZ | China | $855M | -38% | +16% | 21% | 14.2× | -1.6% | +7.9% |
| Kingfa Science & Technology (India) KINGFA.NS | India | $849M | +20% | +24% | 14% | n/a | n/a | n/a |
| Alkyl Amines Chemicals ALKYLAMINE.NS | India | $849M | -9% | +13% | 17% | 37.4× | 36.2% | +4.3% |